References
- Fischer E G, Morris J H, Kettyle W M. Intrasellar gangliocytoma and syndromes of pituitary hypersecretion. J Neurosurg 1983; 59: 1071–5
- Thorner M O, Perryman R L, Cronin M J, et al. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. J Clin Invest 1983; 70: 965–77
- Woosley R E. Multiple secreting microadenomas as a possible cause of selective transsphenoidal adenomectomy failure. J Neurosurg 1983; 58: 267–9
- Hulting A L, Werner S, Wersall J, et al. Normal growth hormone secretion is rare after microsurgical normalization of growth hormone levels in acromegaly. Acta Med Scand 1982; 212: 401–5
- Schuster L D, Bantle J P, Oppenheimer J H, Seljeskog E L. Acromegaly: Reassessment of the long-term therapeutic effectiveness of transsphenoidal pituitary surgery. Ann Intern Med 1981; 95: 172–4
- Arosio M, Giovanelli M A, Riva E, et al. Clinical use of pre- and postsurgical evaluation of abnormal GH responses in acromegaly. J Neurosurg 1983; 59: 402–8
- Schaison G, Couzinet B, Moatti N, Pertuiset B. Critical study of the growth hormone response to dynamic tests and the insulin growth factor assay in acromegaly after microsurgery. Clin Endocrinol 1983; 18: 541–9
- Spiliotis B E, August G P, Hung W, et al. Growth hormone neurosecretory dysfunction. A treatable cause of short stature. JAMA 1984; 251: 2223–30
- Hamberg C A, Hammer G, Norlen G, Sjogren B. Hypophysectomy in acromegaly. J Clin Endocrinol Metab 1959; 29: 1500–2
- Christy N P. Choosing the best treatment for acromegaly. JAMA 1982; 247: 1320
- Thomas J P. Treatment of acromegaly. Br Med J 1983; 286: 330–2
- Mims R B, Bethune J E. Acromegaly with normal fasting growth hormone concentrations but abnormal growth hormone regulation. Ann Intern Med 1974; 81: 781–4
- Allen J P, Cook D M, Greer M A, et al. Serial plasma growth hormone concentration during selective removal of pituitary tumors in acromegaly. J Neurosurg 1974; 41: 38–43
- Lüdecke D, Miichler H, Steins C. P. Perioperative growth hormone studies during selective adenomectomy in acromegaly. Acta Endocrinol 1975, Suppl. 193: 92
- Liidecke D, Kautzky R, Saeger W, Schrader D. Selective removal of hypersecreting pituitary adenomas? An analysis of endocrine function, operative and microscopical findings in 101 cases. Acta Neurochir 1976; 35: 27–42
- von Werder K, Fahlbusch R. Perioperative GH and PRL levels in acromegalic and hyperprolacti-naemic patients. Eur J Clin Invest 1971; 7: 233–4
- Nesbakken R, Reinlie S, Norman N. Surgical treatment of pituitary adenomas: early or late diagnosis and treatment?. J Oslo City Hosp 1981; 31: 117–27
- Bynke O, Karlberg B E, Kagedal B, Nilsson O R. Early postoperative growth hormone levels predict the result of transsphenoidal tumour removal in acromegaly. Acta Endocrinol 1983; 103: 158–62
- Balldin J, Granérus A K, Lindstedt G, et al. Neroendocrine evidence for increased responsiveness of dopamine receptors in humans following electroconvulsive therapy. Psychopharmacology 1982; 76: 371–6
- Merimee T J. Growth hormone: secretion and action. Endocrinology, L J DeGroot, G F Cahill, Jr, L Martini, et al. Grune & Stratton, New York 1979; Vol. 1: 123–32
- Spindler S R, Mellon S H, Baxter J D. Growth hormone gene transcription is regulated by thyroid and glucocorticoid hormones in cultured rat pituitary tumour cells. J Biol Chem 1982; 257: 11627–32
- Vale W, Vaughan J, Yamamoto G, et al. Effects of synthetic human pancreatic (tumor) GH releasing factor and somatostatin, triiodothyronine and dexamethasone on GH secretion in vitro. Endocrinology 1983; 112: 1553–5
- Lamberts S WJ, Verleun T, Oosterom R. The interrelationship between the effects of somatostatin and human pancreatic growth hormone-releasing factor on growth hormone release by cultured pituitary tumor cells from patients with acromegaly. J Clin Endocrinol Metab 1984; 58: 250–4